Tert-butyl3-thia-8-azabicyclo[3.2.1]octane-8-carboxylate, 98%, 500mg

2-Chlorobenzyl Bromide>98.0%(GC)5g

3-[4-(Aminocarbonyl)-1-piperidinyl]propanoic acid, 95.0%, 5g

Methyl 2-formylisonicotinate, 95.0%, 5g

2-(Piperidin-2-yl)-1H-benzo[d]imidazole, 95.0%, 250mg

2-(3,4-Dichloro-phenyl)-pyrrolidine hydrochloride, 1g

Dihidrocloruro de putrescina, mínimo 97 %, para bioquímica, 25 g, envase de vidrio

5-Methyl-1-(1-methyl-1h-pyrazol-3-yl)-1h-1,2,3-triazole-4-carboxylic acid, 95%, 250mg

6-O-tert-butyl 2-O-ethyl 4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepine-2,6-dicarboxylate, 95+%, 250mg

{2-[(2-chlorobenzyl)thio]ethyl}amine, 1g

6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole, 97.0%, 250mg

tert-butyl 6-oxa-2,9-diazaspiro[4.5]decane-2-carboxylate, 95.0%, 100mg

1,3-bis(((R)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)urea, 97%, 50mg